Dr. James Taylor is a Co-Founder and General Manager of Precision NanoSystems, a global leader in innovative solutions for genetic medicine development. James holds a B.A.Sc. in engineering physics from the University of British Columbia and a Ph.D. in genetics from the Institute for Systems Biology in Seattle, Washington.
James worked at the Seattle-based venture capital firm, Accelerator Corporation, concurrent with his Ph.D., Centre for Drug Research and Development in Vancouver, British Columbia, and has extensive experience in the science and commercialization of microfluidics, nanotechnology and systems biology.
James has been the leader of Precision NanoSystems’s technology and commercialization since inception, following the mission to accelerate the creation of transformative medicine that significantly impacts human wellbeing.